Medroxyprogesterone Acetate Market

The synthetic version of progesterone, 17 -hydroxy-6 -methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected is its acetate derivative. Medroxyprogesterone acetate is administered every 3 months which in turn prevents ovulation and follicular maturation in endometrial thinning producing a contraceptive effect.

Medroxyprogesterone Acetate Market contains market size and forecasts of Medroxyprogesterone Acetate in global, including the following market information:

• Global Medroxyprogesterone Acetate Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Medroxyprogesterone Acetate Market Sales, 2017-2022, 2023-2028, (K Doses)
• Global top five Medroxyprogesterone Acetate companies in 2021 (%)

The global Medroxyprogesterone Acetate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Medroxyprogesterone Acetate include Pfizer, Fangtong Pharma, Gador, Sigma-Aldrich, Teva Pharmaceutical, Greenstone, Serum Internation, West-Coast Pharmaceutical and Arrow Pharma Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Medroxyprogesterone Acetate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Medroxyprogesterone Acetate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Medroxyprogesterone Acetate Market Segment Percentages, by Type, 2021 (%)

• Oral
• Parenteral

Global Medroxyprogesterone Acetate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Medroxyprogesterone Acetate Market Segment Percentages, by Application, 2021 (%)

• Contraceptive
• Hormone Replacement Therapy
• Treatment of Endometriosis
• Other

Global Medroxyprogesterone Acetate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Medroxyprogesterone Acetate Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Medroxyprogesterone Acetate revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Medroxyprogesterone Acetate revenues share in global market, 2021 (%)
• Key companies Medroxyprogesterone Acetate sales in global market, 2017-2022 (Estimated), (K Doses)
• Key companies Medroxyprogesterone Acetate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Fangtong Pharma
• Gador
• Sigma-Aldrich
• Teva Pharmaceutical
• Greenstone
• Serum Internation
• West-Coast Pharmaceutical
• Arrow Pharma Group
• Zuche Pharmaceuticals